Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of Autism Co-Morbid for Attention Deficit Hyperactivity Disorder

NCT00541346 is registered in ClinicalTrials.gov with University of Oklahoma as lead sponsor.

NCT NCT00541346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00541346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of Autism Co-Morbid for Attention Deficit Hyperactivity Disorder
Lead sponsor
University of Oklahoma
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2007
Completion date
February 28, 2010
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder, autism